BIRC5 and cancer: Bcl‐2, Bcl‐XL, survivin, and XIAP have been involved in the resistance of cancer cells to chemotherapy (Ji et al., 2013; Maji et al., 2018; Miyamoto et al., 2014; Real et al., 2002).